Integrative metagenomic analysis reveals distinct gut microbial signatures related to obesity

Xinliang Hu,Chong Yu,Yuting He,Songling Zhu,Shuang Wang,Ziqiong Xu,Shaohui You,Yanlei Jiao,Shu-Lin Liu,Hongxia Bao
DOI: https://doi.org/10.1186/s12866-024-03278-5
IF: 4.465
2024-04-07
BMC Microbiology
Abstract:Obesity is a metabolic disorder closely associated with profound alterations in gut microbial composition. However, the dynamics of species composition and functional changes in the gut microbiome in obesity remain to be comprehensively investigated. In this study, we conducted a meta-analysis of metagenomic sequencing data from both obese and non-obese individuals across multiple cohorts, totaling 1351 fecal metagenomes. Our results demonstrate a significant decrease in both the richness and diversity of the gut bacteriome and virome in obese patients. We identified 38 bacterial species including Eubacterium sp. CAG:274, Ruminococcus gnavus , Eubacterium eligens and Akkermansia muciniphila, and 1 archaeal species, Methanobrevibacter smithii , that were significantly altered in obesity. Additionally, we observed altered abundance of five viral families: Mesyanzhinovviridae , Chaseviridae , Salasmaviridae , Drexlerviridae , and Casjensviridae . Functional analysis of the gut microbiome indicated distinct signatures associated to obesity and identified Ruminococcus gnavus as the primary driver for function enrichment in obesity, and Methanobrevibacter smithii , Akkermansia muciniphila , Ruminococcus bicirculans , and Eubacterium siraeum as functional drivers in the healthy control group. Additionally, our results suggest that antibiotic resistance genes and bacterial virulence factors may influence the development of obesity. Finally, we demonstrated that gut vOTUs achieved a diagnostic accuracy with an optimal area under the curve of 0.766 for distinguishing obesity from healthy controls. Our findings offer comprehensive and generalizable insights into the gut bacteriome and virome features associated with obesity, with the potential to guide the development of microbiome-based diagnostics.
microbiology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to comprehensively explore the differences in composition and function between the gut microbiomes (including bacteria and viruses) of obese patients and non - obese patients. Specifically, by integrating metagenomic sequencing data from multiple cohorts, the researchers aim to: 1. **Analyze the diversity and richness of gut bacteria and viruses in obese patients**: The researchers want to understand whether obesity will cause changes in the diversity and richness of gut bacteria and viruses. 2. **Identify specific microbial species associated with obesity**: By comparing the gut microbiomes of obese patients and non - obese patients, the researchers hope to identify the bacterial and viral species that are significantly altered in obese patients. 3. **Explore the functional changes of obesity - related microorganisms**: In addition to the species - level analysis, the researchers also hope to understand through functional annotation whether the metabolic pathways and functional characteristics of these microorganisms in obese patients have changed. 4. **Evaluate the impact of antibiotic - resistance genes and bacterial virulence factors on the development of obesity**: The researchers also want to explore whether these genes and factors play a role in the development of obesity. 5. **Develop a diagnostic tool based on the gut microbiome**: Finally, the researchers hope to develop a diagnostic method that can distinguish between obese patients and healthy people by analyzing the viral operational taxonomic units (vOTUs) of the gut. Through these research objectives, the paper hopes to provide new insights into the microbial mechanisms of obesity and provide a scientific basis for future diagnostic and treatment methods.